Investigating widely available substances as vaginal microbicides
Author:
- 24 June 2004
- journal article
- research article
- Published by CSIRO Publishing in Sexual Health
- Vol. 1 (2) , 73-79
Abstract
Microbicides to protect women from HIV are urgently needed. Several potential pharmaceutical microbicides are now undergoing obligatory clinical trials to check safety, acceptability and efficacy before approval for use. Microbicides may have side-effects and, paradoxically, their use may increase the risk of acquiring HIV. Several widely available substances have been suggested as microbicides, including substances with a low pH such as lemon juice, vinegar, soft drinks and lactobacillus dairy products. Because of the potential for harm it is important that these substances are tested before their use is widely promoted. After small scale safety and acceptability studies, their promotion needs to be evaluated as a communication intervention.Keywords
This publication has 35 references indexed in Scilit:
- Recommendations for the Nonclinical Development of Topical Microbicides for Prevention of HIV Transmission: An UpdateJAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
- Transmission, acute HIV-1 infection and the quest for strategies to prevent infectionNature Medicine, 2003
- Vaginal microbicidesCurrent Opinion in Infectious Diseases, 2002
- Recommendations for the clinical development of topical microbicides: an updateAIDS, 2001
- Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, UgandaThe Lancet, 2001
- Simian Immunodeficiency Virus Rapidly Penetrates the Cervicovaginal Mucosa after Intravaginal Inoculation and Infects Intraepithelial Dendritic CellsJournal of Virology, 2000
- Vaginal Lactobacilli, Microbial Flora, and Risk of Human Immunodeficiency Virus Type 1 and Sexually Transmitted Disease AcquisitionThe Journal of Infectious Diseases, 1999
- Viricidal effect of Lactobacillus acidophilus on human immunodeficiency virus type 1: possible role in heterosexual transmission.Journal of Experimental Medicine, 1991
- Anti-HIV substances for rape victims1989
- Disinfection and Inactivation of the Human T Lymphotropic Virus Type III/Lymphadenopathy-Associated VirusThe Journal of Infectious Diseases, 1985